Condensed Consolidated Statements of Operations (unaudited) - USD ($) $ in Thousands	3 Months Ended
	Jun. 30, 2023	Jun. 30, 2022
Income Statement [Abstract]
Revenue, net, including related parties (Note 11)	$ 5,883	$ 5,156
Cost of goods sold	3,795	4,050
Gross profit	2,088	1,106
Operating expenses:
Research and development	2,869	1,740
Sales and marketing	1,482	1,083
General and administrative	4,516	3,317
Total operating expenses	8,867	6,140
Loss from operations	(6,779)	(5,034)
Interest expense	8	182
Loss in joint venture	860	582
Other income, net	(200)	(445)
Loss before tax expense	(7,447)	(5,353)
Tax expense	0	0
Net loss	(7,447)	(5,353)
Deemed dividend related to warrant modification and issuance of Inducement warrants (Note 8)	5,612	0
Net loss attributable to common stockholders	(13,059)	(5,353)
Net loss attributable to common stockholders	$ (13,059)	$ (5,353)
Net loss per share - basic (in usd per share)	$ (0.22)	$ (0.10)
Net loss per share - diluted (in usd per share)	$ (0.22)	$ (0.10)
Weighted average common shares outstanding - basic (in shares)	59,264,378	54,404,830
Weighted average common shares outstanding - diluted (in shares)	59,264,378	54,404,830